However, TIMM17A has been rarely studied in cancers, and only two studies suggested that high TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer [22], and facilitates migration and invasion of breast cancer cells [21]. The gene discussed is TIMM17A; the disease is breast carcinoma.